FutureFuel Corp. FF

Healthcare SIC 2860 - Industrial Organic Chemicals NYSE

FutureFuel Corp. ("FutureFuel," the "Company," "we," "us," or "our," and includes our wholly-owned subsidiaries) is a Delaware corporation operating primarily through our subsidiary, FutureFuel Chemical Company. We manufacture a diverse portfolio of inorganic chemicals, bio-based specialty chemicals, and biofuels in our integrated facility in Batesville, Arkansas.

FutureFuel is publicly traded on the New York Stock Exchange ("NYSE") under the ticker symbol "FF". Our headquarters are located at our facility in Batesville, Arkansas.

Unless noted otherwise, all financial figures in this report are presented in thousand United States dollars, excluding per-share data.

We maintained a consistent commitment to returning value to our shareholders.

Last close 5.26 2026-09-04
Market cap $230.7M 2026-06-30 share count
52-week range 3.09 - 6.99

Valuation FY2025 figures against the last close

P/S2.4x
P/E
P/FCF
EV/EBITDA
Dividend yield4.6%
Diluted EPS-1.13

Annual financial statements

Income statement

Fiscal year FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Revenue $95.7M$243.3M$368.2M$396.0M$321.4M$204.5M$205.2M$291.0M$275.0M$253.2M
Cost of revenue $191.8M$224.2M$191.7M
Gross profit -$39.4M$19.6M$41.0M$29.0M$23.5M$31.3M$74.1M$73.4M$20.3M$46.9M
R&D $3.9M$4.0M$4.4M$3.4M$3.5M$3.0M$3.2M$3.5M$3.7M$2.7M
SG&A $9.7M$9.3M$9.2M$8.0M
Total operating expenses $13.6M$13.3M$13.6M$11.4M$10.6M$9.0M$8.8M$10.0M$10.4M$10.3M
Operating income -$53.0M$6.4M$27.4M$17.5M$12.9M$22.3M$65.3M$63.4M$9.9M$36.5M
Interest expense $153.0K$138.0K$138.0K$128.0K$131.0K$151.0K$173.0K$173.0K$172.0K$173.0K
Pre-tax income -$49.2M$16.3M$37.4M$13.7M$15.9M$31.8M$79.8M$60.2M$16.6M$40.8M
Income tax $165.0K$792.0K$1.0K$1.5M$10.3M$14.8M$8.4M$7.0M$6.9M$15.5M
Net income -$49.4M$15.5M$37.4M$15.2M$26.3M$46.6M$88.2M$53.2M$23.5M$56.3M
EPS, basic -1.130.350.850.350.601.062.021.220.541.29
EPS, diluted -1.130.350.850.350.601.062.021.220.541.29
Shares, diluted (wtd. avg.) $43.9M$43.8M$43.8M$43.8M$43.8M$43.7M$43.7M$43.7M$43.7M$43.5M

Balance sheet

Fiscal year FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash and equivalents $51.3M$109.5M$219.4M$175.6M$137.5M$198.1M$243.3M$215.0M$114.6M$199.3M
Short-term investments $0$37.1M$47.2M$64.4M$73.6M$79.9M$120.7M$106.1M
Receivables $9.4M$21.9M$28.4M$26.2M$29.3M$21.4M$110.3M$16.3M$22.0M$24.4M
Inventory $21.3M$20.6M$25.4M$26.8M$26.9M$33.9M$37.6M$39.3M$43.8M$52.1M
Total current assets $100.5M$164.8M$290.5M$273.8M$255.8M$342.6M$480.9M$362.3M$310.4M$405.3M
Property, plant and equipment $86.8M$78.5M$72.7M$76.9M$82.9M$91.5M$98.6M$103.6M$109.7M$118.2M
Other intangibles $0$1.4M$1.4M$1.4M$1.4M$1.4M
Total assets $192.2M$247.7M$367.1M$356.0M$344.3M$441.3M$586.5M$471.2M$425.6M$529.0M
Accounts payable $22.2M$28.5M$14.9M$12.5M$61.3M$20.0M$18.4M$22.8M
Total current liabilities $17.7M$33.3M$41.3M$56.1M$35.1M$33.0M$82.8M$39.5M$35.3M$144.0M
Total liabilities $37.5M$41.9M$57.2M$73.0M$55.4M$69.4M$119.4M$82.1M$74.0M$196.2M
Retained earnings -$49.1M$383.0K$27.4M$508.0K$6.3M$89.5M$184.6M$106.9M$61.2M$48.2M
Total equity $154.7M$205.8M$309.9M$283.0M$288.9M$371.9M$467.1M$389.1M$351.6M$332.8M

Cash flow

Fiscal year FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Operating cash flow -$28.7M$24.8M$21.3M$52.5M$44.1M$96.4M$34.6M$85.6M$39.3M$91.0M
Depreciation and amortisation $9.7M$9.2M$10.3M$10.5M$10.5M$11.2M$12.1M$11.2M$11.6M$10.8M
Stock-based compensation $1.0M$359.0K$0$46.0K$0$49.0K$21.0K$357.0K$998.0K$1.9M
Capital expenditure $17.2M$14.7M$6.0M$4.8M$1.5M$4.5M$7.0M$4.9M$3.6M$4.5M
Investing cash flow -$18.6M-$14.8M$33.0M-$3.8M$15.0M$474.0K$4.2M$25.4M-$13.2M-$35.2M
Financing cash flow -$10.9M-$119.9M-$10.5M-$10.5M-$119.7M-$142.1M-$10.5M-$10.7M-$110.8M-$10.5M
Dividends paid $10.5M$119.9M$10.5M$10.5M$119.9M$141.7M$10.5M$10.5M$110.7M$10.5M

Figures as tagged in each year's own filing, in US dollars. A year restated by a later filing shows the restated figure. Capital expenditure, dividends and buybacks are cash out, shown positive. A line the filer does not report is not listed. Latest from accession 0001437749-26-027325.

Others in SIC 2860

TickerCompanyMarket capP/ERevenue growth
IFF INTERNATIONAL FLAVORS & FRAGRANCES INC $22.03B -5.2%
LYB LyondellBasell Industries N.V. $20.52B -9.7%
WLK WESTLAKE CORP $9.56B -8.0%
NEU NEWMARKET CORP $8.14B 19.9x -2.2%
SXT SENSIENT TECHNOLOGIES CORP $5.74B 42.7x 3.5%
REX REX AMERICAN RESOURCES Corp $1.38B 16.6x 1.2%
GPRE Green Plains Inc. $1.08B 16.0%
WLKP Westlake Chemical Partners LP $771.2M 2.7%